[99mTc]Tc-PSMA-T1, [99mTc]Tc-PSMA-T2, [99mTc]Tc-PSMA-T3, [99mTc]Tc-PSMA-T4 and [99mTc]Tc-iPSMA (reference substance for in vivo study) were labeled in the presence of 5 mg of EDDA, 50 mg of tricine dissolved in 0.5 mL of 0.1 M phosphate buffer pH 7.4. After dissolution of reagents, 20 µg of PSMA, 20 µL of 1 mg/mL SnCl2, 2H2O solution in 0.1 M HCl, and 0.6–1 GBq of sodium pertechnetate (99mTc) solution were added. The labeling mixture was incubated for 15 min at 95 °C.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.